Anoikis, initiated by Mcl-1 degradation and Bim induction, is deregulated during oncogenesis
about
Monosaccharide digitoxin derivative sensitize human non-small cell lung cancer cells to anoikis through Mcl-1 proteasomal degradationTLE1 is an anoikis regulator and is downregulated by Bit1 in breast cancer cellsCaveolin-1 regulates Mcl-1 stability and anoikis in lung carcinoma cellsRegulation of Bim in Health and DiseaseA protein kinase Cdelta-dependent protein kinase D pathway modulates ERK1/2 and JNK1/2 phosphorylation and Bim-associated apoptosis by asbestosRoles of caveolin-1 on anoikis resistance in non small cell lung cancerAnoikis resistance: an essential prerequisite for tumor metastasisProteasomal degradation of Mcl-1 by maritoclax induces apoptosis and enhances the efficacy of ABT-737 in melanoma cellsCXCL12 chemokine expression and secretion regulates colorectal carcinoma cell anoikis through Bim-mediated intrinsic apoptosis.Maritoclax induces apoptosis in acute myeloid leukemia cells with elevated Mcl-1 expressionThe virus-induced protein APOBEC3G inhibits anoikis by activation of Akt kinase in pancreatic cancer cells.Akt3-mediated resistance to apoptosis in B-RAF-targeted melanoma cells.TLR4 ligand/H₂O₂ enhances TGF-β1 signaling to induce metastatic potential of non-invasive breast cancer cells by activating non-Smad pathways.Cyclin D1 promotes anchorage-independent cell survival by inhibiting FOXO-mediated anoikis.β3 integrin promotes TGF-β1/H2O2/HOCl-mediated induction of metastatic phenotype of hepatocellular carcinoma cells by enhancing TGF-β1 signaling.Targeted inhibition of FAK, PYK2 and BCL-XL synergistically enhances apoptosis in ovarian clear cell carcinoma cell lines.High Prevalence of the BIM Deletion Polymorphism in Young Female Breast Cancer in an East Asian Country.Understanding micrometastatic disease and Anoikis resistance in ewing family of tumors and osteosarcoma.Mechanisms of cancer cell metastasis to the bone: a multistep process.Discovery of marinopyrrole A (maritoclax) as a selective Mcl-1 antagonist that overcomes ABT-737 resistance by binding to and targeting Mcl-1 for proteasomal degradationBim, a proapoptotic protein, up-regulated via transcription factor E2F1-dependent mechanism, functions as a prosurvival molecule in cancer.Mechanisms that link the oncogenic epithelial-mesenchymal transition to suppression of anoikis.Chemotherapy resistance and metastasis-promoting effects of thyroid hormone in hepatocarcinoma cells are mediated by suppression of FoxO1 and Bim pathway.Bim: guardian of tissue homeostasis and critical regulator of the immune system, tumorigenesis and bone biology.Brefeldin A reduces anchorage-independent survival, cancer stem cell potential and migration of MDA-MB-231 human breast cancer cells.Metastatic SW620 colon cancer cells are primed for death when detached and can be sensitized to anoikis by the BH3-mimetic ABT-737.p53siRNA therapy reduces cell proliferation, migration and induces apoptosis in triple negative breast cancer cells.Imperatorin sensitizes anoikis and inhibits anchorage-independent growth of lung cancer cells.Pokemon silencing leads to Bim-mediated anoikis of human hepatoma cell QGY7703.Pleiotropic action of AP-1 in v-Src-transformed cells.SRC directly phosphorylates Bif-1 and prevents its interaction with Bax and the initiation of anoikis.The first EGF domain of coagulation factor IX attenuates cell adhesion and induces apoptosis.A signal-based method for finding driver modules of breast cancer metastasis to the lung.miR-301a promotes pancreatic cancer cell proliferation by directly inhibiting Bim expression.Cycloartobiloxanthone Induces Human Lung Cancer Cell Apoptosis via Mitochondria-dependent Apoptotic Pathway.Deconstructing Signaling Pathways in Cancer for Optimizing Cancer Combination Therapies.Priming stem cells with protein kinase C activator enhances early stem cell-chondrocyte interaction by increasing adhesion molecules
P2860
Q23923209-DA0775F7-AF23-4C0F-BB60-4CFD1411D06FQ24298072-FC0BF39A-8B75-4FB0-B104-C6C92C7E8E73Q24303545-FDA2A071-F87E-40EE-966C-9570F5AC1A45Q26781203-5F97EA04-3134-4A3D-9796-A751E936E6F2Q28387182-F07F9680-84BF-4005-8476-F15FBCBE70ECQ28389527-274F7B3C-6D2B-4C20-9618-BAD64D861CABQ28397372-F34AC34B-0F35-44FD-A67F-C30B4191280EQ28534817-80088FE0-6378-4869-9CDB-D7BB1103B90DQ33705126-D10E4BF0-0CAF-477C-9E09-EF7143DA2F42Q33989964-01D3FEFD-0DFA-4F7E-8DCB-AA3447040464Q34044486-AF66559B-006D-481A-86C3-382F7D693320Q34069302-1BA22655-4E34-4111-91ED-DC23B90C3D29Q34756109-7DA9C620-9A35-45B9-9EE3-36DD19D0B506Q34764094-C8229CF4-E135-4D15-806C-A6E8C75B43DCQ35048745-0C75EA5F-807C-4CF7-956C-5B512DC5532FQ35093687-030FFE88-032F-4624-9602-2819074EF39AQ35536735-3B5C9BE7-7CB3-468B-9588-B8B7EE7D5D27Q35584126-AC638E90-0644-44DF-A1C3-58F79AD65B1BQ35673417-1F75DD15-2041-4D71-9581-B1459C4B5D74Q35880102-0443D64A-B5C3-433E-85F0-79BF75C78210Q36508651-99C7672B-9661-4DE6-88F9-01FCEF96E505Q36702544-F7D08F2E-5D3C-4ECD-B63B-12ECA3B6DE85Q37412481-FF90DB6B-7704-49D3-8332-9AF5F7AF15F2Q37883974-8CB98112-B4C9-41CA-943F-B75BF8350CF3Q38943889-D812DF83-C5CB-4403-8BC5-2B07A18C6E33Q39096646-D639E25F-C6A2-4EDC-9C9C-FC03CB0B1F09Q39121067-8B6FDBB9-6F1A-43A0-9910-837F4BC27EAFQ39251807-6EA33C58-5589-44E7-84F0-30F24BF4BDFAQ39320859-5FA5BFFA-6D99-4483-9C3A-BDA1D6EC8999Q39555554-C1CB9F26-CFAA-42F8-8D1C-DA35EF550C83Q39627698-ADEBE43F-39A6-41F2-9DC4-09674AADB8D6Q39809447-5ED27125-78DA-47A0-926D-2BE8FA1D27B3Q41564767-0E20A008-9AD3-4053-AACC-163FF5C38409Q44780191-83DCF8D6-1BFF-40E3-BC5F-6793B66D9611Q47257484-8C78FA6A-ECBE-4A3E-AD0F-A049CE99A071Q54969934-F34F4CC8-8C1E-4C83-A3BC-A2FF8C56FFE7Q58544078-DA69F510-CFE8-4D90-B747-9B7337952432
P2860
Anoikis, initiated by Mcl-1 degradation and Bim induction, is deregulated during oncogenesis
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Anoikis, initiated by Mcl-1 de ...... deregulated during oncogenesis
@ast
Anoikis, initiated by Mcl-1 de ...... deregulated during oncogenesis
@en
type
label
Anoikis, initiated by Mcl-1 de ...... deregulated during oncogenesis
@ast
Anoikis, initiated by Mcl-1 de ...... deregulated during oncogenesis
@en
prefLabel
Anoikis, initiated by Mcl-1 de ...... deregulated during oncogenesis
@ast
Anoikis, initiated by Mcl-1 de ...... deregulated during oncogenesis
@en
P2093
P2860
P1433
P1476
Anoikis, initiated by Mcl-1 de ...... deregulated during oncogenesis
@en
P2093
Francis Y Lee
Hirohito Yamaguchi
Hong-Gang Wang
Kapil N Bhalla
Nicholas T Woods
P2860
P304
10744-10752
P356
10.1158/0008-5472.CAN-07-3148
P407
P577
2007-11-01T00:00:00Z